Literature DB >> 8874187

Contribution of both STAT and SRF/TCF to c-fos promoter activation by granulocyte-macrophage colony-stimulating factor.

D Rajotte1, H B Sadowski, A Haman, K Gopalbhai, S Meloche, L Liu, G Krystal, T Hoang.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic growth factor that has been shown to support call proliferation in murine fibroblasts engineered to stably express both chains of the human GM-CSF receptor (NIH-GMR). Because the proto-oncogene c-fos is believed to provide a link between short-term signals elicited at the membrane and long-term cellular response, we chose to study the mechanism of GM-CSF-dependent cell regulation using c-fos promoter activity as a molecular marker in both NIH-GMR transfectants and in the CD34+ cell line TF-1. The importance of c-fos and related AP-1 activity in GM-CSF signalling was suggested by a tight correlation between GM-CSF-dependent activation of the c-fos promoter and cell proliferation and by the inhibitory effect of a trans-dominant c-fos mutant on cell growth. To evaluate the contribution of the serum response factor (SRF) associated with the ternary complex factor (TCF) and of STAT proteins to c-fos promoter activation in response to GM-CSF, the SRF binding site (SRE) and/or the STAT binding site (SIE) were inactivated. In serum-free medium, both SRE and SIE are essential to c-fos promoter activation by GM-CSF in NIH-GMR transfectants and in TF-1 cells. No response to GM-CSF was observed when both sites were mutated. The nature of the STAT family member was further investigated by Wester blots and DNA retardation assays using an SIE probe. Our data indicate that GM-CSF induced DNA binding of both STAT1 and STAT3 in NIH-GMR and mainly of STAT3 in TF-1 cells. STAT5 tyrosine phosphorylation was also observed in TF-1 cells. Finally, expression of a dominant negative MAPK mutant, ERK192A, resulted in a decrease of both SRE- and SIE-dependent activation of c-fos promoter by GM-CSF, suggesting that STAT1/3 are regulated not only by tyrosine kinases, but also partially by MAPK.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8874187

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Chromatin acetylation and remodeling at the Cis promoter during STAT5-induced transcription.

Authors:  Anne Rascle; Emma Lees
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

2.  The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB.

Authors:  J M Wang; J R Chao; W Chen; M L Kuo; J J Yen; H F Yang-Yen
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  Serum response factor-GATA ternary complex required for nuclear signaling by a G-protein-coupled receptor.

Authors:  S Morin; P Paradis; A Aries; M Nemer
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.

Authors:  C Bousquet; M C Zatelli; S Melmed
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 5.  STAT signaling in the pathogenesis and treatment of cancer.

Authors:  D A Frank
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

6.  Src family kinases are required for prolactin induction of cell proliferation.

Authors:  J A Fresno Vara ; M A Cáceres; A Silva; J Martín-Pérez
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

7.  The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors.

Authors:  Q Pang; S Fagerlie; T A Christianson; W Keeble; G Faulkner; J Diaz; R K Rathbun; G C Bagby
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

8.  CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy.

Authors:  Kathleen M Sakamoto; David A Frank
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

9.  Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes.

Authors:  S J Lane; I M Adcock; D Richards; C Hawrylowicz; P J Barnes; T H Lee
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

10.  RARα-PLZF oncogene inhibits C/EBPα function in myeloid cells.

Authors:  Nathalie Girard; Mathieu Tremblay; Magali Humbert; Benoît Grondin; André Haman; Jean Labrecque; Bing Chen; Zhu Chen; Sai-Juan Chen; Trang Hoang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.